Clinical Trials Browser

Phase EARLY_PHASE1 × Withdrawn × Fluorodeoxyglucose F18 × Clear all

NCT03295695 2020-12-04

PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient

Phase EARLY_PHASE1 Withdrawn

Breast Neoplasms, Breast Neoplasms, Male